These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 9758712)

  • 21. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fuel utilization in subjects with carnitine palmitoyltransferase 2 gene mutations.
    Ørngreen MC; Dunø M; Ejstrup R; Christensen E; Schwartz M; Sacchetti M; Vissing J
    Ann Neurol; 2005 Jan; 57(1):60-6. PubMed ID: 15622536
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Heterogeneity of carnitine palmitoyltransferase deficiencies. Deficiency of CPT I in the hepatic form and CPT II in the muscular form].
    Bonnefont JP; Ogier H; Mitchell G; Demaugre F; Pelet A; Saudubray JM; Frezal J
    Arch Fr Pediatr; 1985; 42 Suppl 1():613-7. PubMed ID: 4083994
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Muscle Carnitine Palmitoyltransferase II (CPT II) Deficiency: A Conceptual Approach.
    Joshi PR; Zierz S
    Molecules; 2020 Apr; 25(8):. PubMed ID: 32295037
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Rhabdomyolysis in carnitine palmitoyltransferase II deficiency: developments in pathophysiology, diagnosis and therapy].
    Imoberdorf R; Krähenbühl S; Krapf R
    Schweiz Med Wochenschr; 1998 Jun; 128(25):1024-9. PubMed ID: 9691338
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carnitine palmitoyltransferase II deficiency due to a novel gene variant in a patient with rhabdomyolysis and ARF.
    Kaneoka H; Uesugi N; Moriguchi A; Hirose S; Takayanagi M; Yamaguchi S; Shigematsu Y; Yasuno T; Sasatomi Y; Saito T
    Am J Kidney Dis; 2005 Mar; 45(3):596-602. PubMed ID: 15754283
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel nonsense mutation (515del4) in muscle carnitine palmitoyltransferase II deficiency.
    Deschauer M; Wieser T; Schröder R; Zierz S
    Mol Genet Metab; 2002 Feb; 75(2):181-5. PubMed ID: 11855939
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prenatal diagnosis of carnitine palmitoyltransferase 2 deficiency in chorionic villi: a novel approach.
    Vekemans BC; Bonnefont JP; Aupetit J; Royer G; Droin V; Attié-Bitach T; Saudubray JM; Thuillier L
    Prenat Diagn; 2003 Nov; 23(11):884-7. PubMed ID: 14634971
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Muscle carnitine palmitoyltransferase II deficiency: clinical and molecular genetic features and diagnostic aspects.
    Deschauer M; Wieser T; Zierz S
    Arch Neurol; 2005 Jan; 62(1):37-41. PubMed ID: 15642848
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carnitine palmitoyltransferases 1 and 2: biochemical, molecular and medical aspects.
    Bonnefont JP; Djouadi F; Prip-Buus C; Gobin S; Munnich A; Bastin J
    Mol Aspects Med; 2004; 25(5-6):495-520. PubMed ID: 15363638
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lethal neonatal and severe late infantile forms of carnitine palmitoyltransferase II deficiency associated with compound heterozygosity for different protein truncation mutations.
    Vladutiu GD; Quackenbush EJ; Hainline BE; Albers S; Smail DS; Bennett MJ
    J Pediatr; 2002 Nov; 141(5):734-6. PubMed ID: 12410208
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of 16 novel mutations in the argininosuccinate synthetase gene and genotype-phenotype correlation in 38 classical citrullinemia patients.
    Gao HZ; Kobayashi K; Tabata A; Tsuge H; Iijima M; Yasuda T; Kalkanoglu HS; Dursun A; Tokatli A; Coskun T; Trefz FK; Skladal D; Mandel H; Seidel J; Kodama S; Shirane S; Ichida T; Makino S; Yoshino M; Kang JH; Mizuguchi M; Barshop BA; Fuchinoue S; Seneca S; Zeesman S; Knerr I; Rodés M; Wasant P; Yoshida I; De Meirleir L; Abdul Jalil M; Begum L; Horiuchi M; Katunuma N; Nakagawa S; Saheki T
    Hum Mutat; 2003 Jul; 22(1):24-34. PubMed ID: 12815590
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of the infant-type R631C mutation in patients with the benign muscular form of CPT2 deficiency.
    Musumeci O; Aguennouz M; Comi GP; Rodolico C; Autunno M; Bordoni A; Baratta S; Taroni F; Vita G; Toscano A
    Neuromuscul Disord; 2007 Dec; 17(11-12):960-3. PubMed ID: 17651973
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CPT2 gene mutations resulting in lethal neonatal or severe infantile carnitine palmitoyltransferase II deficiency.
    Isackson PJ; Bennett MJ; Lichter-Konecki U; Willis M; Nyhan WL; Sutton VR; Tein I; Vladutiu GD
    Mol Genet Metab; 2008 Aug; 94(4):422-427. PubMed ID: 18550408
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Muscle Carnitine Palmitoyltransferase II Deficiency: A Review of Enzymatic Controversy and Clinical Features.
    Lehmann D; Motlagh L; Robaa D; Zierz S
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28054946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carnitine/acylcarnitine translocase deficiency (neonatal phenotype): successful prenatal and postmortem diagnosis associated with a novel mutation in a single family.
    Yang BZ; Mallory JM; Roe DS; Brivet M; Strobel GD; Jones KM; Ding JH; Roe CR
    Mol Genet Metab; 2001 May; 73(1):64-70. PubMed ID: 11350184
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carnitine palmitoyltransferase II deficiency: a clinical, biochemical, and molecular review.
    Sigauke E; Rakheja D; Kitson K; Bennett MJ
    Lab Invest; 2003 Nov; 83(11):1543-54. PubMed ID: 14615409
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tandem mass spectrometric assay for the determination of carnitine palmitoyltransferase II activity in muscle tissue.
    Rettinger A; Gempel K; Hofmann S; Gerbitz KD; Bauer MF
    Anal Biochem; 2002 Mar; 302(2):246-51. PubMed ID: 11878804
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel metabolic and molecular findings in hepatic carnitine palmitoyltransferase I deficiency.
    Korman SH; Waterham HR; Gutman A; Jakobs C; Wanders RJ
    Mol Genet Metab; 2005 Nov; 86(3):337-43. PubMed ID: 16146704
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neonatal carnitine palmitoyltransferase II deficiency associated with Dandy-Walker syndrome and sudden death.
    Yahyaoui R; Espinosa MG; Gómez C; Dayaldasani A; Rueda I; Roldán A; Ugarte M; Lastra G; Pérez V
    Mol Genet Metab; 2011 Nov; 104(3):414-6. PubMed ID: 21641254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.